Sibley K - Search Results

1

High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia.

Rollinson S, Allan JM, Law GR, Roddam PL, Smith MT, Skibola C, Smith AG, Forrest MS, Sibley K, Higuchi R, Germer S, Morgan GJ. Rollinson S, et al. Among authors: sibley k. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):795-800. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159312

2

Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, Skibola CF, Smith MT, Morgan GJ. Sibley K, et al. Cancer Res. 2003 Aug 1;63(15):4327-30. Cancer Res. 2003. PMID: 12907599

3

A molecular study of the t(4;14) in multiple myeloma.

Sibley K, Fenton JA, Dring AM, Ashcroft AJ, Rawstron AC, Morgan GJ. Sibley K, et al. Br J Haematol. 2002 Aug;118(2):514-20. doi: 10.1046/j.1365-2141.2002.03618.x. Br J Haematol. 2002. PMID: 12139740 Free article.

4

Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.

Fenton JA, Pratt G, Rawstron AC, Sibley K, Rothwell D, Yates Z, Dring A, Richards SJ, Ashcroft AJ, Davies FE, Owen RG, Child JA, Morgan GJ. Fenton JA, et al. Among authors: sibley k. Oncogene. 2003 Feb 20;22(7):1103-13. doi: 10.1038/sj.onc.1206335. Oncogene. 2003. PMID: 12592397

5

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.

Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. Williams SV, et al. Genes Chromosomes Cancer. 2002 May;34(1):86-96. doi: 10.1002/gcc.10050. Genes Chromosomes Cancer. 2002. PMID: 11921286

6

Redefining a critical region of LOH on 4p16.3 in bladder cancer.

Sibley K, Bell S, Knowles MA. Sibley K, et al. Genes Chromosomes Cancer. 2000 Dec;29(4):378-9. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1045>3.0.co;2-k. Genes Chromosomes Cancer. 2000. PMID: 11066086 No abstract available.

7

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT. Randerson-Moor JA, et al. Among authors: sibley k. Hum Mol Genet. 2001 Jan 1;10(1):55-62. doi: 10.1093/hmg/10.1.55. Hum Mol Genet. 2001. PMID: 11136714

8

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

Sibley K, Cuthbert-Heavens D, Knowles MA. Sibley K, et al. Oncogene. 2001 Feb 8;20(6):686-91. doi: 10.1038/sj.onc.1204110. Oncogene. 2001. PMID: 11314002

9

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

Sibley K, Stern P, Knowles MA. Sibley K, et al. Oncogene. 2001 Jul 19;20(32):4416-8. doi: 10.1038/sj.onc.1204543. Oncogene. 2001. PMID: 11466624

10

Validity of dried blood spot testing for sexually transmitted and blood-borne infections: A narrative systematic review.

Cholette F, Périnet S, Neufeld B, Bryson M, Macri J, Sibley KM, Kim J, Driedger SM, Becker ML, Sandstrom P, Meyers AFA, Paquette D. Cholette F, et al. Among authors: sibley km. PLOS Glob Public Health. 2024 Jun 14;4(6):e0003320. doi: 10.1371/journal.pgph.0003320. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38875246 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page